A Study to Evaluate the Effects of Rifampin on Single-Dose Pharmacokinetics of Canagliflozin in Healthy Volunteers

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to evaluate blood levels of canagliflozin in healthy volunteers before and after the administration of multiple-doses of rifampin.

Key facts

Study ID

NCT01395927

Run by

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

People needed

14

Starts

2011-07-01

Expected to finish

2011-08-01

Last updated by the study team

2013-05-06

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy volunteers with a body mass index between 18 and 30 kg/m2 (inclusive)

You may not qualify if…

• History of or current medical illness deemed clinically significant by the Investigator

Where it is running

• Study site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.